Institutional Ownership
Telomir Pharmaceuticals Inc
CUSIP 87975F104COMTELOQ1 2026
13D / 13G Filings
2
Schedule 13D/13G on record
Beneficial Filers
1
Distinct reporting persons
Largest Stake
9.4%
Max % of class reported
Institutional Holders
24
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
2 filings · latest Feb 12, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 12, 2026 | John Paul Dejoria, As Trustee Of The John Paul Dejoria Family Trust, And In His Individual Capacity | 13G/A | 9.4% | 3.25M | SEC |
| 2 | Sep 18, 2025 | John Paul Dejoria, As Trustee Of The John Paul Dejoria Family Trust, And In His Individual Capacity | 13G | 5.5% | 1.77M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 289.2K | $376.0K |
| 2 | Geode Capital Management, LLC | 249.1K | $324.0K |
| 3 | Millennium Management LLC | 129.1K | $167.8K |
| 4 | State Street Corp | 58.6K | $76.2K |
| 5 | Bank Of New York Mellon Corp | 51.5K | $66.9K |
| 6 | Suncoast Equity Management | 51.2K | $66.6K |
| 7 | Northern Trust Corp | 41.8K | $54.4K |
| 8 | World Investment Advisors | 37.0K | $48.1K |
| 9 | Xtx Topco Ltd | 36.1K | $46.9K |
| 10 | Osaic Holdings, Inc. | 35.8K | $46.5K |